JE00BYSS4X48
JE00BYSS4X48
NovoCure Limited
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.7B EUR | 1.76B EUR | 1.26B EUR | 1.45B EUR |
Enterprise Value | 1.45B EUR | 1.9B EUR | 1.41B EUR | 1.61B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -18.08x | -- | -- | -- |
Price to Sales | 2.43x | 2.52x | 1.87x | 2.91x |
Price to Book | 5.02x | 5.22x | 3.82x | 4.27x |
EV/Revenue | 2.07x | 2.72x | 2.09x | 3.22x |
EV/EBITDA | -10.62x | -- | -- | -- |
Price to FCF (P/FCF) | 74.58x | -- | -- | -- |
EV/FCF | 63.64x | -- | -- | -- |
FCF Yield | 1.34% | -1.44% | -3.81% | -2.02% |